# Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/postmarketing-safety-reporting-for-human-drug-and-biological-products-including-vaccines-draft-guidance-for-industry/c479f7a0-a940-4f91-b4b6-db286a5af68b

> FDA guidance document: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines: Draft Guidance for Industry. Issue date: March 12, 2001. Get complete insights and analysis.

---

## Details

- Title: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-03-12
- Last Changed: 2020-04-27
- Docket Number: <a href="https://www.regulations.gov/docket/ FDA-2001-D-0506"> FDA-2001-D-0506</a>

## Related Documents

- [Submitting Debarment Certification Statements](https://www.globalkeysolutions.net/guidances/guidance-document/submitting-debarment-certification-statements/02f51441-128a-4fc9-a874-1feac482d4d7)
- [How to Comply with the Pediatric Research Equity Act](https://www.globalkeysolutions.net/guidances/guidance-document/how-to-comply-with-the-pediatric-research-equity-act/beb13ca3-608c-4121-93d4-787450c752ba)
- [Applications Covered by Section 505(b)(2)](https://www.globalkeysolutions.net/guidances/guidance-document/applications-covered-by-section-505b2/5f0df47f-0a4f-498e-9b76-34682f4067f5)